Molecular phenotypes of bovine blastocyst derived from in vitro-matured oocyte supplemented with PAPP-A

Vet Res Commun. 2023 Sep;47(3):1263-1272. doi: 10.1007/s11259-023-10072-7. Epub 2023 Jan 18.

Abstract

Insulin-like growth factor-1 (IGF-1) regulates cellular lipid content, whereas pregnancy-associated plasma protein-A (PAPP-A) increases IGF-1 bioavailability. Using in vitro-matured cumulus-oocyte complexes, we aimed to evaluate the impact of PAPP-A on the blastocyst lipid content, embryo cryotolerance and embryonic transcriptional profile. We determined that PAPP-A did not affect the lipid content of oocytes, blastocysts, or blastocyst yield (P > 0.05). However, PAPP-A modulated the embryo transcriptional profiles by downregulating PPARGC1A and AKR1B1, which are related to lipid metabolism; CASP9, a pro-apoptotic gene; and IFN-τ, a marker of embryo quality (P < 0.05). Furthermore, the use of PAPP-A improved blastocyst re-expansion in the first 3 h of culture after vitrification (P < 0.05). Although PAPP-A did not affect the blastocyst lipid content or embryo production, we suggest that embryonic transcriptional modulation could contribute to maintain the balance in embryo lipid metabolism. Furthermore, PAPP-A's approach seems to control key intracellular pathways that improve post-cryopreservation development of blastocysts.

Keywords: Blastocyst; Cattle; Gene expression; Lipid content; Oocyte in vitro maturation; PAPP-A.

MeSH terms

  • Animals
  • Blastocyst / metabolism
  • Cattle
  • Embryonic Development
  • Fertilization in Vitro / veterinary
  • In Vitro Oocyte Maturation Techniques / veterinary
  • Insulin-Like Growth Factor I* / metabolism
  • Lipids
  • Oocytes / metabolism
  • Phenotype
  • Pregnancy-Associated Plasma Protein-A* / genetics
  • Pregnancy-Associated Plasma Protein-A* / metabolism

Substances

  • Pregnancy-Associated Plasma Protein-A
  • Insulin-Like Growth Factor I
  • Lipids